THEOPHYLLINE INCREASES CORONARY VASCULAR TONE IN HUMANS - EVIDENCE FOR A ROLE OF ENDOGENOUS ADENOSINE IN FLOW REGULATION

Citation
A. Edlund et A. Sollevi, THEOPHYLLINE INCREASES CORONARY VASCULAR TONE IN HUMANS - EVIDENCE FOR A ROLE OF ENDOGENOUS ADENOSINE IN FLOW REGULATION, Acta Physiologica Scandinavica, 155(3), 1995, pp. 303-311
Citations number
45
Categorie Soggetti
Physiology
ISSN journal
00016772
Volume
155
Issue
3
Year of publication
1995
Pages
303 - 311
Database
ISI
SICI code
0001-6772(1995)155:3<303:TICVTI>2.0.ZU;2-E
Abstract
To elucidate the role of adenosine in coronary vasoregulation, we stud ied the effects of adenosine antagonism (by theophylline) on coronary blood flow at different levels of adenosine formation (stimulated by h ypoxia and exercise). Six healthy subjects were studied. Coronary sinu s (CS) blood flow (thermodilution) and cardiac oxygen extraction {(A-C S)O2D} were determined while breathing room air at rest, and 12% oxyge n, both at rest and during light exercise, on two occasions. One of th e experiments was performed during infusion of theophylline. The basal CS flow was 118 (67-168) mL min(-1) (mean and 95% confidence interval ), and the (A-CS)O2D was 125 (111-142) mL L(-1). Inhalation of 12% O-2 decreased the arterial haemoglobin oxygen saturation to 83 (80-86)% a t rest and to 77 (73-81)% during exercise. CS flow increased to 167 (9 3-214) and 261 (179-343) mL min(-1), respectively, and (A-CS)O2D decre ased to 102 (85-119) and 94 (77-111) mL L(-1), respectively. Theophyll ine, at a dose lacking effects on myocardial work, markedly attenuated the coronary flow response to exogenous adenosine, and decreased CS f low to 89 (58-119), 120 (79-161) and 190 (162-218) mL min(-1) at normo xic rest, hypoxic rest and hypoxic exercise, respectively. The overall decrease amounted to 23% (P < 0.05). The calculated coronary vascular conductance also decreased by 23% (P < 0.05) and (A-CS)O2D increased by 15% (P < 0.001). In conclusion, the data support the hypothesis tha t endogenous adenosine is involved in regulation of human coronary ton e.